Abstract:The PITSLRE protein kinases are parts of the large family of p34cdc2-related kinases. During apoptosis induced by some stimuli, specific PITSLRE isoforms are cleaved by caspase to produce a protein that contains the C-terminal kinase domain of the PITSLRE proteins (p110C). The p110C induces apoptosis when it is ectopically expressed in Chinese hamster ovary cells. In our study, similar induction of this p110C was observed during anoikis in NIH3T3 cells. To investigate the molecular mechanism of apoptosis mediated by p110C, we used the yeast two-hybrid system to screen a human fetal liver cDNA library and identified p21-activated kinase 1 (PAK1) as an interacting partner of p110C. The association of p110C with PAK1 was further confirmed by in vitro binding assay, in vivo coimmunoprecipitation, and confocal microscope analysis. The interaction of p110C with PAK1 occurred within the residues 210–332 of PAK1. Neither association between p58PITSLRE or p110PITSLRE and PAK1 nor association between p110C and PAK2 or PAK3 was observed. Anoikis was increased and PAK1 activity was inhibited when NIH3T3 cells were transfected with p110C. Furthermore, the binding of p110C with PAK1 and inhibition of PAK1 activity were also observed during anoikis. Taken together, these data suggested that PAK1 might participate in the apoptotic pathway mediated by p110C. The PITSLRE protein kinases are parts of the large family of p34cdc2-related kinases. During apoptosis induced by some stimuli, specific PITSLRE isoforms are cleaved by caspase to produce a protein that contains the C-terminal kinase domain of the PITSLRE proteins (p110C). The p110C induces apoptosis when it is ectopically expressed in Chinese hamster ovary cells. In our study, similar induction of this p110C was observed during anoikis in NIH3T3 cells. To investigate the molecular mechanism of apoptosis mediated by p110C, we used the yeast two-hybrid system to screen a human fetal liver cDNA library and identified p21-activated kinase 1 (PAK1) as an interacting partner of p110C. The association of p110C with PAK1 was further confirmed by in vitro binding assay, in vivo coimmunoprecipitation, and confocal microscope analysis. The interaction of p110C with PAK1 occurred within the residues 210–332 of PAK1. Neither association between p58PITSLRE or p110PITSLRE and PAK1 nor association between p110C and PAK2 or PAK3 was observed. Anoikis was increased and PAK1 activity was inhibited when NIH3T3 cells were transfected with p110C. Furthermore, the binding of p110C with PAK1 and inhibition of PAK1 activity were also observed during anoikis. Taken together, these data suggested that PAK1 might participate in the apoptotic pathway mediated by p110C. Apoptosis is a form of altruistic cell suicide, which is involved in many physiological processes, including tissue homeostasis, embryonic development, and immune response (1Schwartzman R.A. Cidlowski J.A. Endocr. Rev. 1993; 14: 133-151Crossref PubMed Scopus (898) Google Scholar, 2Maller J.L. Curr. Opin. Cell Biol. 1991; 3: 269-275Crossref PubMed Scopus (96) Google Scholar). It is becoming increasingly clear that cell cycle regulators such as the p34cdc2 gene family could influence apoptosis (3Yonish-Rouach E. Grunwald D. Wilder S. Kimchi A. May E. Lawrence J.J. May P. Oren M. Mol. Cell. Biol. 1993; 13: 1415-1423Crossref PubMed Scopus (354) Google Scholar, 4Weinberg R.A. Cell. 1995; 81: 323-330Abstract Full Text PDF PubMed Scopus (4326) Google Scholar, 5Berry D.E. Lu Y. Schmidt B. Fallon P.G. O'Connell C. Hu S.X. Xu H.J. Blanck G. Oncogene. 1996; 12: 1809-1819PubMed Google Scholar, 6Shan B. Lee W.H. Mol. Cell. Biol. 1994; 14: 8166-8173Crossref PubMed Scopus (474) Google Scholar, 7Shi L. Nishioka W.K. Th'ng J. Bradbury E.M. Litchfield D.W. Greenberg A.H. Science. 1994; 263: 143-145Crossref Scopus (572) Google Scholar). The PITSLRE protein kinases, which are coded by the gene localized to human chromosome 1p36.3 and a syntenic region of mouse chromosome 4, are parts of the large family of p34cdc2-related kinases (8Bunnell B.A. Heath L.S. Adams D.E. Lahti J.M. Kidd V.J. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 7467-7471Crossref PubMed Scopus (126) Google Scholar, 9Eipers P.G. Barnoski B.L. Han J. Carroll A.J. Kidd V.J. Genomics. 1991; 11: 621-629Crossref PubMed Scopus (42) Google Scholar, 10Meyerson M. Enders G.H. Wu C.L. Su L.K. Gorka C. Nelson C. Harlow E. Tsai L.H. EMBO J. 1992; 11: 2909-2917Crossref PubMed Scopus (788) Google Scholar, 11Xiang J. Lahti J.M. Grenet J. Easton J. Kidd V.J. J. Biol. Chem. 1994; 269: 15786-15794Abstract Full Text PDF PubMed Google Scholar, 12Mock B.A. Padlan C. Kozak C.A. Kidd V. Mamm. Genome. 1994; 5: 191-192Crossref PubMed Scopus (10) Google Scholar, 13Lahti J.M. Valentine M. Xiang J. Jones B. Amann J. Grenet J. Richmond G. Look A.T. Kidd V.J. Nat. Genet. 1994; 7: 370-375Crossref PubMed Scopus (111) Google Scholar, 14Gururajan R. Lahti J.M. Grenet J. Easton J. Gruber I. Ambros P.F. Kidd V.J. Genome. Res. 1998; 8: 929-939Crossref PubMed Scopus (52) Google Scholar). There are at least 20 PITSLRE protein kinase isoforms, which are differentially expressed in mammalian tissues and regulate diverse cellular functions, including the cell cycle control, tumorigenesis, the regulation of RNA splicing or transcription, and so on (8Bunnell B.A. Heath L.S. Adams D.E. Lahti J.M. Kidd V.J. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 7467-7471Crossref PubMed Scopus (126) Google Scholar, 10Meyerson M. Enders G.H. Wu C.L. Su L.K. Gorka C. Nelson C. Harlow E. Tsai L.H. EMBO J. 1992; 11: 2909-2917Crossref PubMed Scopus (788) Google Scholar, 11Xiang J. Lahti J.M. Grenet J. Easton J. Kidd V.J. J. Biol. Chem. 1994; 269: 15786-15794Abstract Full Text PDF PubMed Google Scholar,13Lahti J.M. Valentine M. Xiang J. Jones B. Amann J. Grenet J. Richmond G. Look A.T. Kidd V.J. Nat. Genet. 1994; 7: 370-375Crossref PubMed Scopus (111) Google Scholar, 14Gururajan R. Lahti J.M. Grenet J. Easton J. Gruber I. Ambros P.F. Kidd V.J. Genome. Res. 1998; 8: 929-939Crossref PubMed Scopus (52) Google Scholar, 15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 16Beyaert R. Kidd V.J. Cornelis S. Van de Craen M. Denecker G. Lahti J.M. Gururajan R. Vandenabeele P. Fiers W. J. Biol. Chem. 1997; 272: 11694-11697Abstract Full Text Full Text PDF PubMed Scopus (124) Google Scholar, 17Tang D. Kidd V.J. J. Biol. Chem. 1998; 273: 28549-28552Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 18Ariza M.E. Broome-Powell M. Lahti J.M. Kidd V.J. Nelson M.A. J. Biol. Chem. 1999; 274: 28505-28513Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, 19Nelson M.A. Ariza M.E. Yang J.M. Thompson F.H. Taetle R. Trent J.M. Wymer J. Massey-Brown K. Broome-Powell M. Easton J. Lahti J.M. Kidd V.J. Cancer. Genet. Cytogenet. 1999; 108: 91-99Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar, 20Dave B.J. Pickering D.L. Hess M.M. Weisenburger D.D. Armitage J.O. Sanger W.G. Cancer. Genet. Cytogenet. 1999; 108: 120-126Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar, 21Loyer P. Trembley J.H. Lahti J.M. Kidd V.J. J. Cell Sci. 1998; 111: 1505-1506Crossref Google Scholar, 22Trembley J.H. Hu D. Hsu L.C. Yeung C.Y. Slaughter C. Lahti J.M. Kidd V.J. J. Biol. Chem. 2002; 277: 2589-2596Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 23Dickinson L.A. Edgar A.J. Ehley J. Gottesfeld J.M. J. Biol. Chem. 2002; 277: 25465-25473Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar, 24Zhang S.W. Xu S.L. Cai M.M. Yan J. Zhu X.Y. Hu Y. Gu J.X. Mol. Cell. Biochem. 2001; 221: 161-168Crossref PubMed Scopus (14) Google Scholar, 25Zhang S.W. Cai M.M. Zhang S. Xu S.L. Chen S. Chen X.N. Chen C. Gu J.X. J. Biol. Chem. 2002; 277: 35314-35322Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 26Cai M.M. Zhang S.W. Zhang S. Chen S. Yan J. Zhu X.Y. Hu Y. Chen C. Gu J.X. Mol. Cell. Biochem. 2002; 238: 49-55Crossref PubMed Scopus (8) Google Scholar). Studies indicated that several of the PITSLRE protein kinase isoforms might serve as effectors in apoptotic signaling pathways (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 16Beyaert R. Kidd V.J. Cornelis S. Van de Craen M. Denecker G. Lahti J.M. Gururajan R. Vandenabeele P. Fiers W. J. Biol. Chem. 1997; 272: 11694-11697Abstract Full Text Full Text PDF PubMed Scopus (124) Google Scholar, 17Tang D. Kidd V.J. J. Biol. Chem. 1998; 273: 28549-28552Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 18Ariza M.E. Broome-Powell M. Lahti J.M. Kidd V.J. Nelson M.A. J. Biol. Chem. 1999; 274: 28505-28513Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). During apoptosis induced by Fas or tumor necrosis factor, the action of p110C, a novel processed PITSLRE isoform resulting from the proteolysis of specific larger PITSLTR isoforms, significantly increased (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 18Ariza M.E. Broome-Powell M. Lahti J.M. Kidd V.J. Nelson M.A. J. Biol. Chem. 1999; 274: 28505-28513Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). Previous studies of our group and others (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 26Cai M.M. Zhang S.W. Zhang S. Chen S. Yan J. Zhu X.Y. Hu Y. Chen C. Gu J.X. Mol. Cell. Biochem. 2002; 238: 49-55Crossref PubMed Scopus (8) Google Scholar) showed that apoptosis was increased when p110C was ectopically expressed in Chinese hamster ovary cells or SMMC 7721 hepatocarcinoma cells. These data suggested that p110C might play an important role in mediating apoptosis. In this study, we also detected the expression of p110C in NIH3T3 cells during anoikis, which is a form of apoptosis induced by the disruption of cell-matrix interaction. In agreement with the previous studies, a similar induction of p110C was observed during anoikis in NIH3T3 cells. It seems that p110C could participate in apoptosis induced by different factors. However, little is known about the mechanism of p110C-mediated apoptotic signaling pathway. Previous studies of the p58PITSLRE or p110PITSLRE isoforms showed that they could interact with different proteins and mediate different cellular functions. For example, p110PITSLRE isoform interacted with the RNA-binding protein RNPS1, RNA polymerase II, and multiple transcriptional elongation factors, regulating some aspects of RNA splicing or transcription in proliferating cells (21Loyer P. Trembley J.H. Lahti J.M. Kidd V.J. J. Cell Sci. 1998; 111: 1505-1506Crossref Google Scholar, 22Trembley J.H. Hu D. Hsu L.C. Yeung C.Y. Slaughter C. Lahti J.M. Kidd V.J. J. Biol. Chem. 2002; 277: 2589-2596Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar), whereas the p58PITSLRE isoform interacted with cyclin D3 in the G2/M phase of the cell cycle, regulating G2/M phase cell cycle progression (24Zhang S.W. Xu S.L. Cai M.M. Yan J. Zhu X.Y. Hu Y. Gu J.X. Mol. Cell. Biochem. 2001; 221: 161-168Crossref PubMed Scopus (14) Google Scholar, 25Zhang S.W. Cai M.M. Zhang S. Xu S.L. Chen S. Chen X.N. Chen C. Gu J.X. J. Biol. Chem. 2002; 277: 35314-35322Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). Thus, the identification of cellular proteins that do interact with p110C, physically and/or functionally, should be a useful approach for defining the cellular functions and regulatory mechanisms of p110C in apoptotic signaling pathways. To investigate this issue, the yeast two-hybrid system with p110C as bait was used to screen a human fetal liver cDNA library. As a result, PAK1 1The abbreviations used are: PAK1, p21-activated kinase 1; HA, influenza hemagglutinin monoclonal antibody epitope; GST, glutathione S-transferase; ECL, enhanced chemiluminescence; EGFP, enhanced green fluorescent protein; PBS, phosphate-buffered saline; MBP, myelin basic protein; aa, amino acid(s); PMSF, phenylmethylsulfonyl fluoride; PVDF, polyvinylidene difluoride; FITC, fluorescein isothiocyanate; DMEM, Dulbecco's modified Eagle's medium; PI, propidium iodide; PS, phosphatidylserine; JNK, c-Jun N-terminal kinase; poly-HEMA, poly(2-hydroxyethyl methacrylate). (p21-activated kinase 1) was identified as a p110C-associated protein via the domain (aa 210–332). This association of p110C with PAK1 was specific, as verified by the inability of PAK2 or PAK3 to associate with p110C and the inability of PAK1 to associate with p58PITSLRE or p110PITSLRE. Anoikis was increased and PAK1 activity was inhibited when NIH3T3 cells were transfected with p110C. Furthermore, the association of p110C, with PAK1 and inhibition of PAK1 activity, was also observed when anoikis was induced in NIH3T3 cells. Taken together, the data suggested that PAK1 might play a role in the regulation of p110C-mediated apoptotic signaling pathway. Cell Lines and Reagents—The NIH3T3 cells and SMMC 7721 cells were obtained from the Institute of Cell Biology, Academic Sinica. The mammalian expression vector pcDNA3 was from Invitrogen (Carlsbad, CA). MATCHMAKER LexA two-hybrid system and human fetal liver MATCHMAKER LexA cDNA library were products of Clontech (Palo Alto, CA). The rabbit polyclonal anti-PITSLRE antibody and the goat polyclonal anti-γ-PAK antibody were purchased from Santa Cruz Biotechnology. The rabbit polyclonal anti-PAK1 and the anti-rabbit-horseradish peroxidase secondary antibodies were purchased from New England BioLabs. The rabbit polyclonal anti-PAK3 antibody was from Calbiochem. Protein G-agarose, glutathione-Sepharose beads, and the mouse monoclonal anti-HA (12CA5) antibody were purchased from Roche Applied Science. Leupeptin, aprotinin, PMSF, poly-HEMA, and MBP were purchased from Sigma Chemical Co. [γ-32P]ATP (>3000 Ci/mm), [35S]methionine, Hybond PVDF membrane, and the enhanced chemiluminescence (ECL) assay kit were purchased from Amersham Biosciences. Annexin V-FITC recombinant protein was purchased from Bender MedSystems. Other reagents were commercially available in China. Cell Culture, Transient Transfection, and Induction of Anoikis— NIH3T3 cells were cultured with DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. SMMC 7721 cells were cultured with RPMI 1640 supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. They were maintained in a 37 °C humidified atmosphere containing 5% CO2 in air. For transient transfection assays, the cells (5 × 105) were grown on 60-mm tissue culture dishes. The following day, the cells were transfected with relevant plasmids. The transfection was performed with LipofectAMINETM according to the manufacturer's recommendations. After 48 h, the cells were harvested for further analysis. For induction of anoikis (27Ibuki Y. Goto R. Biochem. Biophys. Res. Commun. 2000; 279: 872-878Crossref PubMed Scopus (32) Google Scholar), NIH3T3 cells were seeded in 3 × 106 cells/100-mm tissue culture dish. After culturing for 6 h, the medium was changed to serum-free DMEM. Following a further culturing for 18 h, the cells were trypsinized and plated in cell suspension dishes previously coated with 10 mg/ml poly-HEMA. After indicated time, the cells were collected for further investigation. Apoptosis was evaluated by staining with propidium iodide (PI) to detect subdiploid DNA content and by using annexin V to detect cell surface phosphatidylserine (PS). For PI staining, the cells (106) were washed twice, collected, and then fixed with 70% ethanol at –20 °C overnight. After staining with 10 μg/ml propidium iodide, the cells were analyzed on a BD Biosciences fluorescence-activated cell sorter. The percentage of apoptosis was quantitated from sub-G1 events. To use annexin V to detect cell surface PS, the cells were washed twice in PBS and then resuspended in binding buffer (10 mm Hepes/NaOH, pH 7.4, 140 mm NaCl, 2.5 mm CaCl2). 195 μl of cell suspension containing 105 cells was taken, and 5 μl of annexin V-FITC was added, mixed, and incubated for 10 min in the dark. After that, the cells were wash twice in PBS and resuspended in 190 μl of binding buffer. 10 μl of 20 μg/ml PI was added and then analyzed by fluorescence-activated cell sorting. Apoptotic cells could be stained with annexin V but not PI. Western Blot Analysis—Western blot experiments were used to measure certain proteins. Briefly, the cells were lysed in lysis buffer (120 mm Tris (pH 7.4), 135 mm NaCl, 1 mm EDTA, 1% Nonidet P-40, 0.1% SDS, 1 mm Na3VO4, 1 mm aprotinin, 1 mm PMSF). A total of 50 μg of protein from each sample was electrophoresed by 12% SDS-PAGE and then transferred to a PVDF membrane. After blocking with PBS containing 5% nonfat milk and 0.1% Tween 20 overnight, the membrane was incubated with primary antibody at 4 °C overnight. After washing with PBS containing 0.1% Tween 20 three times, each for 5 min, the membrane was then incubated with horseradish peroxidase-labeled secondary antibody for another 2 h at room temperature. The membrane was then developed using the enhanced chemiluminescent (ECL) detection system. Yeast Two-hybrid cDNA Library Screening and Protein-Protein Interaction Assay—MATCHMAKER LexA two-hybrid system was used to perform yeast two-hybrid screening according to the manufacturer's instruction. The p110C was used as bait to screen by the reporter genes LEU2 and lacZ. The transformed yeast was grown on plates lacking both histidine to select the bait plasmid and tryptophan to select the prey plasmid, respectively. The individual cDNA of interest was purified from the positive clones and re-transformed into yeast to confirm its specific interaction with p110C. 14 clones could activate both the LEU2 and lacZ reporter genes only when they contain pLexA-p110C. All of these clones were revealed to encode the fragment of p21-activated kinase 1 (PAK1) by sequence analysis. The quantitative β-galactosidase assay was performed to detect the protein-protein interaction on at least three independent colonies from the same clone, using o-nitrophenyl-β-d-galactopyranoside as a substrate. Murine p53 fused with LexA as a bait and SV40 large T-antigen fused as a prey were used as a positive control. Construction of the p110C and the Mutants of PAK1—pLexA-p110C containing the C-terminal PITSLRE p110 coding sequence (GenBankTM accession number U04824, nucleotides 1357–2451) was constructed. The p110C was generated by PCR using p110PITSLRE cDNA (a gift from Dr. Sigrid Cornelis) as template and using primer 1 (5′-GATGAATTCATGTGCCGGAGCGTCGAGGAG-3′, EcoRI site underlined), primer 2 (5′-GATGTCGACTTAGAACTTGAGGCTGAA-3′, SalI site underlined). pcDNA3-HA-p110C and pcNDA3-GST-p110C with a GST fusion at the N-terminal were constructed by inserting the same PCR product of p110C in-frame into the EcoRI and XhoI sites of pcDNA3-HA vector or pcDNA3-GST vector. The full-length of p110 was cut from pSV-sport-p110PITSLRE by EcoRI and XbaI and cloned into pcDNA3-HA vector. The full-length cDNA and mutants of PAK1 were designated as FL (aa 1–545), N (aa 1–270), C (aa 271–545), F1 (aa 1–456), F2 (aa 1–394), F3 (aa 1–332), F4 (aa 150–332), F5 (aa 210–332), F6 (aa 240–332), and F7 (aa 210–300) and performed by PCR using pcMV6-myc-PAK1 (wt) (a gift from Dr. Gary Bokoh) as template. FL was generated from primer 3 (5′-GATGAATTCATGTCAAATAACGGCCTAGAC-3′) and primer 4 (5′-GATCTCGAGTTAGTGATTGTTCTTTGT-3′), N from primers 3 and 5 (5′-GATGTCGACTTATTTCTTCTTAGGATCGCC-3′), C from primer 6 (5′-GATGAATTCATGTATACACGGTTTGAGAAG-3′) and primer 4, F1 from primer 3 and primer 7 (5′-GATCTCGAGTTATTCGATGGCCATGATGCC-3′), F2 from primer 3 and primer 8 (5′-GATCTCGAGTTAATTGTCACTCTTGATGTC-3′), F3 from primer 3 (5′-GATCTCGAGTTAGTCCAAGTAATTCACAAT) and primer 9, F4 from primer 10 (5′-GATGAATTCATGGCTGAGGATTACAATTCT-3′) and primer 9, F5 from primer 11 (5′-GATGAATTCATGCCTGTCACTCCAACTCGG-3′) and primer 9, F6 from primer 12 (5′-GATGAATTCATGGAGAAGCAGAAGAAG-3′) and primer 9, and F7 from primer 11 and primer 13 (5′-GATCTCGAGTTACTGCTTAATGGCCTC-3′) by PCR separately. The EcoRI site underlined in the forward primer and the XhoI site underlined in the reverse primer were used to clone these fragments into pB42AD plasmid or pcDNA3 vector. The PAK2 was cloned into pB42AD plasmid or pcDNA3 vector by PCR using PAK2 cDNA (a gift from Dr. Gray Bokoch) as template, and using primer 14 (5′-GATGAATTCATGTCTGATAACGGAGAACTG-3′, EcoRI site underlined) and primer 15 (5′-GATCTCGAGTTAACGGTTACTCTTCATTGC-3′, XhoI site underlined). The PAK3 was cloned into pB42AD plasmid or pcDNA3 vector by PCR using mPAK3 cDNA (a gift from Dr. Richard A. Cerione) as template and using primer 16 (5′-GATGAATTCATGTCTGACAGCTTGGATAAC-3′, EcoRI site underlined) and primer 17 (5′-GATCTCGAGCTAACGGCTACTGTTCTTAAT-3′, XhoI site underlined). In Vitro Binding Analysis—p110C was cloned into pcDNA3-GST vector. PAK1 and its mutants, PAK2, and PAK3 were cloned into pcDNA3 individually. Their transcripts were produced by using an in vitro transcription kit (Promega). Rabbit reticulocyte lysates from Promega were used to generate [35S]Met-labeled proteins, which were used immediately for binding studies. The binding reactions were performed in protein binding buffer (20 mm Tris, pH 7.5, 50 mm NaCl, 10% glycerol, 10 mm NaF, 1% Nonidet P-40, 1 mm NaVO4, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mm PMSF) at 4 °C for 2 h with constant mixing (28Bagheri-Yarmand R. Mandal M. Taludker A.H. Wang R.A. Vadlamudi R.K. Kung H.J. Kumar R. J. Biol. Chem. 2001; 276: 29403-29409Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar). The beads were washed three times with the same buffer, and the bound proteins were subjected to 12% SDS-PAGE analysis. The gel was then dried and autoradiographed. In Vivo Interaction Assay—48 h after transfection, the cells were washed three times with ice-cold PBS and solubilized with 1 ml of lysis buffer (50 mm Tris-HCl (pH 7.5), 150 mm NaCl, 0.1% Nonidet P-40, 5 mm EDTA, 5 mm EGTA, 15 mm MgCl2, 60 mm β-glycerophosphate, 0.1 mm sodium orthovanadate, 0.1 mm NaF, 0.1 mm benzamide, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mm PMSF). Detergent-insoluble materials were removed by centrifugation at 13,000 rpm for 15 min at 4 °C. Whole cell lysates were incubated with mouse normal IgG (Santa Cruz Biotechnology) or relevant antibody at 4 °C for 2 h. Pre-equilibrated protein G-agarose beads (Roche Applied Science) were then added and collected by centrifugation after 2 h of incubation and then gently washed three times with the lysis buffer. The bound proteins were eluted by boiling in SDS sample buffer and resolved on a 12% SDS-PAGE gel. The proteins were transferred onto a PVDF membrane and analyzed using Western blots. Fluorescence Imaging of Living Cells—The enhanced GFP segment (Clontech) was attached to the C terminus of human p110C by standard recombinant techniques. Briefly, the DNA fragments of p110C was generated by PCR (primer 18: 5′-GATGAATTCATGTGCCGGAGCGTCGAGGAG-3′, EcoRI site underlined; primer 19: 5′-GATGTCGACGAACTTGAGGCTGAAGCC-3′, SalI site underlined), digested with EcoRI and SalI, and then cloned into pEGFPN3 (Clontech) to create pEG-FPN3-p110C. Full-length PAK1 was cloned into the pDsRed1-C1 vector (Clontech) so as to be expressed as a fusion with a red fluorescent protein (DsRed). The fragment of PAK1 was prepared by PCR (primer 20: 5′-GATGTCGACATGTCAAATAACGGCCTAGAC-3′, SalI site underlined; primer 21: 5′-GATGGATCCTTAGTGATTGTTCTTTGT-3′, BamHI site underlined), digested with SalI and BamHI, and then ligated into the pDsRed1-C1 vector to create pDsRed1-C1-PAK1. SMMC 7721 hepatocellular carcinoma cells were transiently co-transfected with pDsRed1-C1-PAK1 and pEGFPN3-p110C. After 48 h, the cells were observed under a fluorescence microscope and digitally photographed. PAK1 Kinase Assay—As described by Chant et al. (29Brown J.L. Stowers L. Baer M. Trejo J. Coughlin S. Chant J. Curr. Biol. 1996; 6: 598-605Abstract Full Text Full Text PDF PubMed Scopus (228) Google Scholar), the cells were washed twice with ice-cold PBS, and lysed at 4 °C in lysis buffer (50 mm Tris-HCl (pH 7.5), 150 mm NaCl, 0.1% Nonidet P-40, 5 mm EDTA, 5 mm EGTA, 15 mm MgCl2, 60 mm β-glycerophosphate, 0.1 mm sodium orthovanadate, 0.1 mm NaF, 0.1 mm benzamide, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mm PMSF). Equal total protein was immunoprecipitated with rabbit polyclonal anti-PAK1 (1:50) at 4 °C overnight. Immune complexes were covered by adding protein G beads and then centrifuged. The beads were washed twice in lysis buffer and twice in kinase buffer (100 mm NaCl, 50 mm Tris (pH 7.5), 10 mm MgCl2, and 1 mm MnCl2). Kinase assays were performed in 50-μl reactions with 50 mm ATP, 10 μCi of [32P]ATP, and 5 μg of MBP. After 30 min at 30 °C, the reactions were terminated by addition of 10 μl of 6× sample buffer, boiled, separated by 15% SDS-PAGE, and analyzed using autoradiography. Quantitation of MBP phosphorylation by PAK1 was determined by phosphorimaging. Induction of p110C Protein during Anoikis in NIH3T3 Cells—Previous studies indicated that transfection of p110C in Chinese hamster ovary cells did not influence mitosis and cell growth but could induce apoptosis (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar). When the apoptosis of cells was induced by treating with Fas antibody or tumor necrosis factor, p110C protein was induced, which was not due to new protein synthesis but processing of some PITSLRE isoforms (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 18Ariza M.E. Broome-Powell M. Lahti J.M. Kidd V.J. Nelson M.A. J. Biol. Chem. 1999; 274: 28505-28513Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). These suggested that p110C might have an important role in apoptotic signaling pathway. To test whether the induction of p110C isoform was in general in response to different apoptotic inducers, NIH3T3 cell apoptosis was induced by detachment from the cell matrix (also known as anoikis), and then the expression of the PITSLRE protein isoforms was detected. Cells undergoing apoptosis could be recognized by flow cytometry by detecting a sub-G1 peak using PI staining and phosphatidylserine (PS) on the outer leaflet of the cell membrane using an annexin V label. About 26% of the NIH3T3 cells cultured in a poly-HEMA-coated dish (detached from the extracellular matrix) under serum-free condition for 10 h underwent apoptosis (Fig. 1A). Western blot analysis using anti-PITSLRE antibody showed that p110C was markedly induced when the cells were induced during anoikis. This result was consistent with the previous studies (15Lahti J.M. Xiang J. Heath L.S. Campana D. Kidd V.J. Mol. Cell. Biol. 1995; 15: 1-11Crossref PubMed Scopus (191) Google Scholar, 18Ariza M.E. Broome-Powell M. Lahti J.M. Kidd V.J. Nelson M.A. J. Biol. Chem. 1999; 274: 28505-28513Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). In addition, it was found that the induction of p110C did not result from the processing of p110 PITSLRE isoform but largely results from cleavage of the p58PITSLRE isoform when anoikis was induced in NIH3T3 cells (Fig. 1B). Therefore, our study also showed the similar induction of p110C during anoikis in NIH3T3 cells. Identification of PAK1 as p110C-associated Protein—To identify proteins that interact with p110C, the yeast two-hybrid system was used with p110C as bait, and a human fetal liver cDNA library was screened. We plated a pool of cells that contained 5 × 107 primary library transformants at a multiplicity of 10 onto selection induction medium. Approximately 40 clones were obtained whose LEU2 and lacZ reporter genes were activated. Among them 14 clones could activate both the LEU2 and lacZ reporter genes only when they contained pLexA-p110C. The DNA of interest was isolated and sequenced. Sequence homology search identified the encoded proteins. All of these peptides were positioned in-frame to the p21-activated kinase (PAK1) and contained a partly N-terminal deletion portion of PAK1. PAK1 was first identified as a Rac-interacting protein (30Manser E. Leung T. Salihuddin H. Zhao Z.S. Lim L. Nature. 1994; 367: 40-46Crossref PubMed Scopus (1305) Google Scholar). There are at least six known PAK isoforms (PAK1–6) that are differentially expressed in mammalian tissues (31Jaffer Z.M. Chernoff J. Int. J. Biochem. Cell Biol. 2002; 34: 713-717Crossref PubMed Scopus (318) Google Scholar, 32Pandey A. Dan I. Kristiansen T.Z. Watanabe N.M. Voldby J. Kajikawa E. Khosravi-Far R. Blagoev B. Mann M. Oncogene. 2002; 21: 3939-3948Crossref PubMed Scopus (103) Google Scholar, 33Dan C. Nath N. Liberto M. Minden A. Mol. Cell. Biol. 2002; 22: 567-577Crossref PubMed Scopus (138) Google Scholar). Based on their conserved structure, PAK1–3 are classed together as the Group I PAKs (34Sells M.A. Chernoff J. Trends. Cell Biol. 1997; 7: 162-167Abstract Full Text PDF PubMed Scopus (265) Google Scholar, 35Knaus U.G. Bokoch G.M. Int. J. Biochem. Cell Biol. 1998; 30: 857-862Crossref PubMed Scopus (161) Google Scholar, 36Bagrodia S. Cerione R.A. Trends. Cell Biol. 1999; 9: 350-355Abstract Full Text Full Text PDF PubMed Scopus (343) Google Scholar). To investigate if PAK1 was the unique one in the Group I PAKs that could interact with p110C, a direct two-hybrid assay was performed. The other two Group I PAKs, PAK2 and PAK3, were co-transformed, respectively, with p110C into EGY48 (p8op-lacZ). Subsequent transformation results showed that neither of them permitted activation of the reporter genes, whereas PAK1, in the presence of p110C, did activate the two report genes. It suggested th

Abstract:The transcription factor NF-κB plays important roles in inflammation and cell survival. NF-κB is composed of homodimeric and heterodimeric complexes of Rel/NF-κB family members, including p65 (RelA), c-Rel (Rel), RelB, NF-κB1/p50, and NF-κB2/p52. Here we report the identification and characterization of a novel ZU5 and death domain-containing protein designated ZUD. In reporter gene assays, overexpression of ZUD inhibited NF-κB-dependent transcription induced by both tumor necrosis factor (TNF) and interleukin-1 and their downstream signaling proteins. Gel shift assays indicated that the overexpression of ZUD inhibited binding of NF-κB to its target sequence. ZUD is a cytoplasmic protein, and coimmunoprecipitation assays indicated that ZUD interacted with the NF-κB subunit p105 and transactivator p65. Consistent with its role in inhibition of NF-κB-dependent transcription, ZUD sensitized cells to apoptosis induced by TNF and the TNF-related apoptosis-inducing ligand (TRAIL). Our findings suggest that ZUD is an inhibitor of NF-κB activation and that this protein may provide an alternative regulatory mechanism for NF-κB-mediated transcription. The transcription factor NF-κB plays important roles in inflammation and cell survival. NF-κB is composed of homodimeric and heterodimeric complexes of Rel/NF-κB family members, including p65 (RelA), c-Rel (Rel), RelB, NF-κB1/p50, and NF-κB2/p52. Here we report the identification and characterization of a novel ZU5 and death domain-containing protein designated ZUD. In reporter gene assays, overexpression of ZUD inhibited NF-κB-dependent transcription induced by both tumor necrosis factor (TNF) and interleukin-1 and their downstream signaling proteins. Gel shift assays indicated that the overexpression of ZUD inhibited binding of NF-κB to its target sequence. ZUD is a cytoplasmic protein, and coimmunoprecipitation assays indicated that ZUD interacted with the NF-κB subunit p105 and transactivator p65. Consistent with its role in inhibition of NF-κB-dependent transcription, ZUD sensitized cells to apoptosis induced by TNF and the TNF-related apoptosis-inducing ligand (TRAIL). Our findings suggest that ZUD is an inhibitor of NF-κB activation and that this protein may provide an alternative regulatory mechanism for NF-κB-mediated transcription. The NF-κB/Rel family of transcription factors play critical roles in the regulation of immune responses, inflammation, apoptosis, and cell survival through induction of a large set of downstream genes, including cytokines, chemokines, adhesion molecules, and effectors (1Siebenlist U. Franzoso G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-445Crossref PubMed Scopus (2003) Google Scholar, 2Baeuerle P.A. Cell. 1998; 95: 729-731Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar, 3Barkett M. Gilmore T.D. Oncogene. 1999; 18: 6910-6924Crossref PubMed Scopus (1064) Google Scholar, 4Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4024) Google Scholar, 5Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1182) Google Scholar, 6Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3260) Google Scholar, 7Karin M. Lin A. Nat. Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2422) Google Scholar). Five members of this family have been identified in vertebrates, including p65 (RelA), c-Rel (Rel), RelB, NF-κB1/p50, and NF-κB2/p52. All of these proteins share a conserved 300-amino acid region known as the Rel homology domain, which is responsible for DNA binding, dimerization, and nuclear translocation of NF-κB. These proteins bind DNA as homo- and hetero-dimers. Two of the active subunits of NF-κB, p50 and p52, are derived from the N-terminal domains of their precursor molecules, p105 and p100, respectively, via post-translational processing of the C-terminal ankyrin repeat-containing domains by the 26 S proteasome (1Siebenlist U. Franzoso G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-445Crossref PubMed Scopus (2003) Google Scholar, 2Baeuerle P.A. Cell. 1998; 95: 729-731Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar). The major cellular form of NF-κB is a heterodimer consisting of the DNA binding subunit p50 and the transactivator p65. Normally, NF-κB is retained in the cytoplasm of unstimulated cells through association with its inhibitor IκB. Upon stimulation by various NF-κB activating signals, IκB is phosphorylated and degraded through an ubiquitin-dependent process. This process frees NF-κB, which is then translocated into the nucleus to activate transcription of its target genes (1Siebenlist U. Franzoso G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-445Crossref PubMed Scopus (2003) Google Scholar, 2Baeuerle P.A. Cell. 1998; 95: 729-731Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar, 3Barkett M. Gilmore T.D. Oncogene. 1999; 18: 6910-6924Crossref PubMed Scopus (1064) Google Scholar, 4Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4024) Google Scholar, 5Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1182) Google Scholar, 6Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3260) Google Scholar, 7Karin M. Lin A. Nat. Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2422) Google Scholar). The transcriptional activity of NF-κB is also modulated by regulation of p65 phosphorylation (4Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4024) Google Scholar, 6Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3260) Google Scholar). TNF 1The abbreviations used are: TNF, tumor necrosis factor; DD, death domain; EST, expressed sequence tag; FADD, Fas-associated DD protein; IFN, interferon; IKK, inhibitory κB kinase; IL-1, interleukin 1; IRF-1, interferon response factor 1; NF-κB, nuclear factor κB; PBS, phosphate-buffered saline; RIP, receptor-interacting protein; SINK, p65-interacting inhibitor of NF-κB; TNF-R1, TNF receptor 1; TRAF, TNF receptor-associated factor; TRADD, tumor necrosis factor receptor-associated DD protein; TRAIL, TNF-related apoptosis-inducing ligand; UNC5H, Caenorhabditis elegans UNC-5 homolog; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; ZUD, ZU5 and death domain-containing protein. 1The abbreviations used are: TNF, tumor necrosis factor; DD, death domain; EST, expressed sequence tag; FADD, Fas-associated DD protein; IFN, interferon; IKK, inhibitory κB kinase; IL-1, interleukin 1; IRF-1, interferon response factor 1; NF-κB, nuclear factor κB; PBS, phosphate-buffered saline; RIP, receptor-interacting protein; SINK, p65-interacting inhibitor of NF-κB; TNF-R1, TNF receptor 1; TRAF, TNF receptor-associated factor; TRADD, tumor necrosis factor receptor-associated DD protein; TRAIL, TNF-related apoptosis-inducing ligand; UNC5H, Caenorhabditis elegans UNC-5 homolog; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; ZUD, ZU5 and death domain-containing protein. is one of the major proinflammatory cytokines that activate NF-κB (8Locksley R.M. Killeen N. Lenardo M.J. Cell. 2001; 104: 487-501Abstract Full Text Full Text PDF PubMed Scopus (2936) Google Scholar). Upon TNF stimulation, TNF receptor 1 (TNF-R1), which contains a cytoplasmic death domain (DD), trimerizes and recruits the downstream DD-containing protein TRADD (TNF-receptor-associated death domain) to the receptor signaling complex (9Hsu H. Xiong J. Goeddel D.V. Cell. 1995; 81: 495-504Abstract Full Text PDF PubMed Scopus (1721) Google Scholar, 10Hsu H. Shu H.B. Pan M.G. Goeddel D.V. Cell. 1996; 84: 299-308Abstract Full Text Full Text PDF PubMed Scopus (1719) Google Scholar). TRADD then functions as an adaptor to recruit several downstream proteins, including FADD (Fas-associated death domain), TRAF2 (TNF receptor-associated factor 2), and RIP (receptor-interacting protein) to the TNF-R1 signaling complex (9Hsu H. Xiong J. Goeddel D.V. Cell. 1995; 81: 495-504Abstract Full Text PDF PubMed Scopus (1721) Google Scholar, 10Hsu H. Shu H.B. Pan M.G. Goeddel D.V. Cell. 1996; 84: 299-308Abstract Full Text Full Text PDF PubMed Scopus (1719) Google Scholar, 11Hsu H. Huang J. Shu H.B. Baichwal V. Goeddel D.V. Immunity. 1996; 4: 387-396Abstract Full Text Full Text PDF PubMed Scopus (964) Google Scholar, 12Shu H.B. Takeuchi M. Goeddel D.V. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 13973-13978Crossref PubMed Scopus (363) Google Scholar). Although FADD is critically involved in TNF-R1-mediated apoptosis, TRAF2 and RIP recruit IKK (IκB kinase) to the TNF-R1 complex (13Devin A. Cook A. Lin Y. Rodriguez Y. Kelliher M. Liu Z. Immunity. 2000; 12: 419-429Abstract Full Text Full Text PDF PubMed Scopus (353) Google Scholar, 14Zhang S.Q. Kovalenko A. Cantarella G. Wallach D. Immunity. 2000; 12: 301-311Abstract Full Text Full Text PDF PubMed Scopus (391) Google Scholar). IKK contains three subunits, the catalytic subunits IKKα and IKKβ and the regulatory subunit IKKγ (6Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3260) Google Scholar). Once IKK is recruited to the TNF-R1 complex, it is activated and subsequently leads to IκB phosphorylation and NF-κB activation (6Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3260) Google Scholar, 7Karin M. Lin A. Nat. Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2422) Google Scholar). Several members of the TNF receptor family contain a conserved DD that is essential for the NF-κB activation and apoptosis induced by these receptors (15Ashkenazi A. Dixit V.M. Science. 1998; 281: 1305-1308Crossref PubMed Scopus (5085) Google Scholar). The DD is also found in several cytoplasmic adapter proteins, including TRADD, FADD, and RIP, and the NF-κB subunits p105 and p100 (15Ashkenazi A. Dixit V.M. Science. 1998; 281: 1305-1308Crossref PubMed Scopus (5085) Google Scholar, 16Chinnaiyan A.M. O'Rourke K. Tewari M. Dixit V.M. Cell. 1995; 81: 505-512Abstract Full Text PDF PubMed Scopus (2144) Google Scholar, 17Boldin M.P. Varfolomeev E.E. Pancer Z. Mett I.L. Camonis J.H. Wallach D. J. Biol. Chem. 1995; 270: 7795-7798Abstract Full Text Full Text PDF PubMed Scopus (937) Google Scholar, 18Stanger B.Z. Leder P. Lee T.H. Kim E. Seed B. Cell. 1995; 81: 513-523Abstract Full Text PDF PubMed Scopus (853) Google Scholar, 19Beinke S. Belich M.P. Ley S.C. J. Biol. Chem. 2002; 277: 24162-24168Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 20Wang Y. Cui H. Schroering A. Ding J.L. Lane W.S. McGill G. Fisherk D.E. Ding H.F. Nat. Cell Biol. 2002; 4: 888-893Crossref PubMed Scopus (54) Google Scholar). The death domain exerts its effects via self-association and/or interaction with death domain of other proteins (15Ashkenazi A. Dixit V.M. Science. 1998; 281: 1305-1308Crossref PubMed Scopus (5085) Google Scholar). Here we report the cloning and characterization of a novel DD-containing protein designated ZUD (ZU5 and death domain-containing protein). In addition to the C-terminal DD, ZUD also contains an N-terminal ZU5 domain that is found in the cytoplasmic domains of UNC5H receptor family members (21Hong K. Hinck L. Nishiyama M. Poo M.P. Tessier-Lavigne M. Stein E. Cell. 1999; 97: 927-941Abstract Full Text Full Text PDF PubMed Scopus (567) Google Scholar, 22Leonardo E.D. Hinck L. Masu M. Keino-Masu K. Ackerman S.L. Tessier-Lavigne M. Nature. 1997; 386: 833-836Crossref PubMed Scopus (420) Google Scholar, 23Ackerman S.L. Kozak L.P. Przyborski S.A. Rund L.A. Boyer B.B. Knowles B.B. Nature. 1997; 386: 838-842Crossref PubMed Scopus (311) Google Scholar, 24Llambi F. Causeret F. Bloch-Gallego E. Mehlen P. EMBO J. 2001; 20: 2715-2722Crossref PubMed Scopus (270) Google Scholar, 25Tanikawa C. Matsuda K. Nakanashi H. Fukuda S. Nakamura Y. Arakawa H. Nat. Cell Biol. 2003; 5: 216-223Crossref PubMed Scopus (152) Google Scholar, 26Thiebault K. Mazelin L. Pays L. Llambi F. Joly M.O. Scoazec J.Y. Saurin J.C. Romeo G. Mehlen P. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4173-4178Crossref PubMed Scopus (166) Google Scholar). Our data demonstrate that ZUD is a cytoplasmic protein associated with p105 and p65 and inhibits NF-κB-dependent transcription. Reagents—The ZUD EST clone (Research Genetics, Huntsville, TN), the recombinant human TNF, IL-1, and IFN-γ (R & D Systems Inc., Minneapolis, MN), the monoclonal antibodies against FLAG (Sigma), Myc (Santa Cruz Biotechnology, Santa Cruz, CA), hemagglutinin epitopes (Covance, Berkeley, CA), and the goat polyclonal antibody against p65 and the rabbit polyclonal antibody against p50 and IκBα (Santa Cruz Biotechnology, Santa Cruz, CA) were purchased from the indicated manufacturers. Recombinant soluble TRAIL was produced in our laboratory (27Hu W.H. Johnson H. Shu H.B. J. Biol. Chem. 1999; 275: 10838-10844Abstract Full Text Full Text PDF Scopus (255) Google Scholar). Human embryonic kidney 293 cells were obtained from the American Type Culture Collection (Manassas, VA). Constructs—Expression plasmids for TNF-R1, TRAF2, TRAF6, IKK-β, p65, p50, and IκBα (Dr. David Goeddel) and the NF-κB (Dr. Gary Johnson) and IRF-1 (Dr. Uli Schindler) luciferase reporter constructs were provided by the indicated investigators. Mammalian expression plasmids for Myc-tagged p105 and its deletion mutants and for hemagglutinin- or FLAG-tagged ZUD and its deletion mutants were constructed by PCR amplification of the corresponding cDNA fragments and subsequent cloning into a cytomegalovirus promoter-based vector. Mammalian expression plasmid for SINK was described previously (28Wu M. Xu L. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar). Northern Blot Hybridization—Human multiple tissue mRNA blots were purchased from Clontech (Palo Alto, CA). The cDNA probe was an ∼1.6-kb fragment corresponding to the coding sequence of amino acids 1-518 of ZUD. The hybridization was performed with the radiolabeled ZUD cDNA probe in rapid hybridization buffer (Clontech, Palo Alto, CA) under high stringency conditions. Cell Transfection and Reporter Gene Assays—293 cells (∼2 × 105) were seeded on 6-well (35-mm) dishes and transfected the following day by the standard calcium phosphate precipitation method (29Sambrook J. Fritch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual.2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1989Google Scholar). Within the same experiment, each transfection was performed in triplicate, and, where necessary, an empty control plasmid was added to ensure that each transfection received the same amount of total DNA. To normalize for transfection efficiency, 0.3 μg of a Rous sarcoma virus β-galactosidase plasmid was added to each transfection. Luciferase reporter assays were performed using a luciferase assay kit (BD PharMingen) and following the manufacturer's protocols. β-galactosidase activity was measured using the Galacto-Light chemiluminescent kit (Tropix, Bedford, MA). Luciferase activities were normalized on the basis of β-galactosidase activities. Co-immunoprecipitation and Western Blot Analysis—Transfected 293 cells from each 100-mm dish were lysed in 1 ml of lysis buffer (20 mm Tris, pH 7.5, 150 mm NaCl, 1% Triton X-100, 1 mm EDTA, 10 μg/ml aprotinin, 10 μg/ml leupeptin, and 1 mm phenylmethylsulfonyl fluoride). For each immunoprecipitation, a 0.4-ml aliquot of lysate was incubated with 0.5 μg of the indicated monoclonal antibody or control mouse IgG and 25 μl of a 1:1 slurry of GammaBind G Plus-Sepharose (Amersham Biosciences) for at least 1 h. The Sepharose beads were washed three times with 1 ml of lysis buffer containing 500 mm NaCl. The precipitates were fractionated on SDS-PAGE, and subsequent Western blot analyses were performed as described (27Hu W.H. Johnson H. Shu H.B. J. Biol. Chem. 1999; 275: 10838-10844Abstract Full Text Full Text PDF Scopus (255) Google Scholar, 28Wu M. Xu L. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar, 29Sambrook J. Fritch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual.2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1989Google Scholar, 30Chen D. Li X. Zhai Z. Shu H.B. J. Biol. Chem. 2002; 277: 15985-15991Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar). Immunofluorescent Staining—293 cells cultured on glass coverslips were sequentially plunged into methanol at -20 °C for 10 min. The cells were rehydrated in PBS, blocked with 1% bovine serum albumin in PBS for 30 min, and stained with a monoclonal anti-FLAG antibody (2 μg/ml) in blocking buffer for 1 h at room temperature. The cells were rinsed with PBS and stained with fluorescein isothiocyanate-conjugated goat anti-mouse IgG (1:200 dilution) for 45 min at room temperature. The cells were then rinsed with PBS containing Hoechst 33342 and mounted in Prolong Antifade (Molecular Probes, Eugene, OR). The cells were observed with a Leica DMR/XA immunofluorescent microscope using a 40× plan objective. Apoptosis Assays—β-Galactosidase co-transfection assays for determination of cell death were performed as described previously (9Hsu H. Xiong J. Goeddel D.V. Cell. 1995; 81: 495-504Abstract Full Text PDF PubMed Scopus (1721) Google Scholar, 10Hsu H. Shu H.B. Pan M.G. Goeddel D.V. Cell. 1996; 84: 299-308Abstract Full Text Full Text PDF PubMed Scopus (1719) Google Scholar, 11Hsu H. Huang J. Shu H.B. Baichwal V. Goeddel D.V. Immunity. 1996; 4: 387-396Abstract Full Text Full Text PDF PubMed Scopus (964) Google Scholar, 28Wu M. Xu L. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar, 31Shu H.B. Halpins D.R. Goeddel D.V. Immunity. 1997; 6: 751-763Abstract Full Text Full Text PDF PubMed Scopus (366) Google Scholar). Briefly, 293 cells (∼2 × 105) were seeded on 6-well (35-mm) dishes and transfected the following day with 0.1 μg of a cytomegalovirus β-galactosidase plasmid and 2 μg of an expression plasmid for ZUD or an empty control plasmid. Approximately 36 h after transfection the cells were stained with X-gal. The numbers of surviving blue cells from five representative viewing fields were determined microscopically. Data shown are averages and standard deviations of one representative experiment in which each transfection has been performed in triplicate. Electrophoretic Mobility Shift Assay—An electrophoretic mobility shift assay was performed as described previously (27Hu W.H. Johnson H. Shu H.B. J. Biol. Chem. 1999; 275: 10838-10844Abstract Full Text Full Text PDF Scopus (255) Google Scholar, 28Wu M. Xu L. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar, 32Xu L.G. Wu M. Hu J. Zhai Z. Shu H.B. J. Leukocyte Biol. 2002; 72: 410-416PubMed Google Scholar). Briefly, 293 cells (∼2 × 106) cells were transfected with 10 μg of empty control plasmid or an expression plasmid for ZUD or SINK. Twenty-four hours after transfection, the cells were treated with TNF (20 ng/ml) for 30 min. The cells were harvested and incubated in 500 μl of Buffer A (10 mm Hepes, 10 mm NaCl, 5 mm EDTA, 1.5 mm MgCl2, 10 μg/ml aprotinin and leupeptin, 2 mm dithiothreitol, and 1 mm phenylmethylsulfonyl fluoride, pH 7.8) at 4 °C for 10 min. Five hundred microliters of Buffer B (Buffer A plus 1.2% Nonidet P-40) was added, and the sample was mixed vigorously for 10 s. The pellet was spun down, washed with buffer A, and resuspended in 4.5 μl of Buffer C (Buffer A plus 10% glycerol). After the addition of 5 μl of 4.1 m NaCl and incubation at 4 °C for 30 min, the sample was centrifuged, and the nuclear extract in the supernatant was quantified with a Bio-Rad protein assay kit. The NF-κB target oligonucleotide 5′-GGGGACTTTCCC-3′ (Santa Cruz Biotechnology), was labeled with [32P]ATP by T4 DNA kinase and incubated with 20 μg of nuclear extract and 0.8 μg poly dI-dC in binding buffer (20 mm Tris, 50 mm KCl, 1 mm EDTA, 1 mm dithiothreitol, 0.1% Nonidet P-40, and 5% glycerol, pH 7.5) at room temperature for 15 min. The mixture was fractionated in 5% acrylamide gel prepared in 0.5× Tris borate-EDTA. The gel was dried and subjected to autoradiography. Identification and Cloning of ZUD—To identify a potential DD-containing protein, we searched the GenBank™ EST databases using the tBLASTn program. This search identified multiple human EST clones that encode a novel DD-containing protein, which was designated ZUD. The longest EST clone (GenBank™ accession number BI762014) encodes the full-length human ZUD protein because it contains an in-frame stop codon 5′ of the putative ATG start codon and a poly(A) signal sequence at the 3′-end (data not shown). Sequence analysis indicated that human ZUD cDNA encodes a 518 amino acid protein (Fig. 1A). BLAST searches of the GenBank™ databases indicated that human ZUD shares ∼83% sequence identity with its mouse ortholog at the amino acid level. Structural analysis indicated that ZUD contains an N-terminal ZU5 domain (aa108-186) (a functionally unknown domain found in ZO-1 and UNC5H receptors), a middle leucine zipper motif (aa 249-270), and a C-terminal death domain (aa 423-491) (Fig. 1A). ZUD is mostly homologous to the cytoplasmic fragments of the UNC5H receptor family members, which also contain a ZU5 domain and a death domain (21Hong K. Hinck L. Nishiyama M. Poo M.P. Tessier-Lavigne M. Stein E. Cell. 1999; 97: 927-941Abstract Full Text Full Text PDF PubMed Scopus (567) Google Scholar, 22Leonardo E.D. Hinck L. Masu M. Keino-Masu K. Ackerman S.L. Tessier-Lavigne M. Nature. 1997; 386: 833-836Crossref PubMed Scopus (420) Google Scholar, 23Ackerman S.L. Kozak L.P. Przyborski S.A. Rund L.A. Boyer B.B. Knowles B.B. Nature. 1997; 386: 838-842Crossref PubMed Scopus (311) Google Scholar, 24Llambi F. Causeret F. Bloch-Gallego E. Mehlen P. EMBO J. 2001; 20: 2715-2722Crossref PubMed Scopus (270) Google Scholar, 25Tanikawa C. Matsuda K. Nakanashi H. Fukuda S. Nakamura Y. Arakawa H. Nat. Cell Biol. 2003; 5: 216-223Crossref PubMed Scopus (152) Google Scholar, 26Thiebault K. Mazelin L. Pays L. Llambi F. Joly M.O. Scoazec J.Y. Saurin J.C. Romeo G. Mehlen P. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4173-4178Crossref PubMed Scopus (166) Google Scholar). The overall similarity between ZUD and the cytoplasmic domains of UNC5H receptors is ∼40%. Northern blot analysis indicated that ZUD is expressed in pancreas, kidney, and liver as transcripts of ∼3 and ∼4kb respectively (Fig. 1B). ZUD mRNA is barely detectable in other examined tissues, including heart, brain, placenta, lung, skeletal muscle, spleen, thymus, prostate, uterus, testis, small intestine, colon, and peripheral blood leukocytes (Fig. 1B). Analysis of available sequences in the GenBank™ databases (cDNAs, ESTs, and genomic sequences) suggests that the more abundant ∼3 kb transcript represents the cDNA sequence we obtained. Because this sequence contains a 5′ in-frame stop codon and no splicing or poly(A) signal variants were identified by the GenBank™ data base searches, the ∼4 kb transcript may represent an alternative splicing form in which additional 5′-untranslated region sequence is included. ZUD Inhibits NF-κB-dependent Transcription—Because ZUD contains a DD, we determined whether ZUD has a role in apoptosis. Transient transfection experiments indicated that overexpression of ZUD could not induce apoptosis or inhibit death receptor-induced apoptosis (data not shown). Because many DD-containing proteins are involved in NF-κB activation and the NF-κB subunits p105 and p100 themselves contain DDs, we determined whether ZUD has a role in NF-κB activation. In reporter gene assays, overexpression of ZUD did not activate NF-κB but significantly inhibited NF-κB activation induced by overexpression of TNF-R1, TRAF2, TRAF6, IKKβ, and p65 (Fig. 2A). Moreover, ZUD could also inhibit NF-κB activation triggered by TNF and IL-1 stimulation (Fig. 2B). In contrast, ZUD did not inhibit IFN-γ-induced IRF-1 activation (Fig. 2C), suggesting that ZUD specifically inhibits TNF and IL-1 triggered NF-κB activation. ZUD Is a Cytoplasmic Protein and Inhibits NF-κB Binding to Its Target Sequence—Because ZUD inhibits p65-mediated transcription in our reporter assays (Fig. 2A), we reasoned that ZUD acts at a downstream step of the NF-κB activation pathways. To determine the potential mechanism, we examined the cellular localization of ZUD by immunofluorescent microscopy. These experiments indicated that ZUD was mostly localized in the cytoplasm and that this localization was not changed by TNF treatment (Fig. 3A). We next determined whether ZUD affects NF-κB transport into the nucleus and binding to its target sequences. Using gel shift assays, we found that ZUD inhibited TNF-induced NF-κB binding to a conserved target sequence (Fig. 3B). In these assays, a control protein, SINK, did not inhibit TNF-induced NF-κB DNA binding activity (Fig. 3B). These data suggest that ZUD functions in the cytoplasm to inhibit NF-κB binding to its target sequence. ZUD Is Associated with p105 and p65—Because ZUD inhibits NF-κB DNA binding activity, we determined whether this inhibitory effect is mediated by physical association between ZUD and NF-κB or IκB components. We co-transfected ZUD and p50, p65, p105, IκBα, IKKα, or IKKβ into 293 cells and performed co-immunoprecipitation experiments. The results indicated that ZUD interacted with p65 and p105 but not with p50, IκBα, IKKα, orIKKβ (Fig. 4, A and B). Consistent with the fact that ZUD interacted with p105 but not p50, domain-mapping experiments indicated that ZUD interacted with the C terminus (aa 535-969) (equivalent to IκBγ) but not the N terminus (aa 1-434) (equivalent to p50) of p105 (Fig. 4B). To determine which domain of ZUD is responsible for its interaction with p105 and p65, we made several deletion mutants of ZUD (Fig. 5A). Transient transfection and co-immunoprecipitation experiments indicated that the middle region containing the leucine zipper motif of ZUD, aa 186-400, is required and sufficient for interaction with p105 and p65 (Fig. 5). ZUD Sensitizes Cells to TNF- and TRAIL-induced Apoptosis—NF-κB promotes cell survival through transcriptional induction of anti-apoptotic genes (2Baeuerle P.A. Cell. 1998; 95: 729-731Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar, 3Barkett M. Gilmore T.D. Oncogene. 1999; 18: 6910-6924Crossref PubMed Scopus (1064) Google Scholar, 7Karin M. Lin A. Nat. Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2422) Google Scholar, 34Wang C.Y. Mayo M.W. Korneluk R.G. Goeddel D.V. Baldwin Jr., A.S. Science. 1998; 281: 1680-1683Crossref PubMed Scopus (2553) Google Scholar, 35Zong W.X. Edelstein L.C. Chen C. Bash J. Gelinas C. Genes Dev. 1999; 13: 382-387Crossref PubMed Scopus (638) Google Scholar, 36Micheau O. Lens S. Gaide O. Alevizopoulos K. Tschopp J. Mol. Cell. Biol. 2001; 21: 5299-5305Crossref PubMed Scopus (679) Google Scholar). Because ZUD inhibits NF-κB-dependent transcription, we determined whether ZUD affects NF-κB-dependent cell survival. We transfected 293 cells with an expression plasmid for ZUD and examined its effect on TNF- and TRAIL-induced apoptosis. The results indicated that overexpression of ZUD significantly sensitized 293 cells to TNF- and TRAIL-induced apoptosis (Fig. 6). In an attempt to clone novel DD-containing proteins, we isolated ZUD by searching human EST databases. ZUD contained a conserved ZU5 domain, a middle leucine zipper motif, and a C-terminal DD. Analysis of the amino acid sequence of ZUD suggests that it is homologous to the cytoplasmic domains of a group of netrin-1 receptors, UNC5H1-4 (21Hong K. Hinck L. Nishiyama M. Poo M.P. Tessier-Lavigne M. Stein E. Cell. 1999; 97: 927-941Abstract Full Text Full Text PDF PubMed Scopus (567) Google Scholar, 22Leonardo E.D. Hinck L. Masu M. Keino-Masu K. Ackerman S.L. Tessier-Lavigne M. Nature. 1997; 386: 833-836Crossref PubMed Scopus (420) Google Scholar, 23Ackerman S.L. Kozak L.P. Przyborski S.A. Rund L.A. Boyer B.B. Knowles B.B. Nature. 1997; 386: 838-842Crossref PubMed Scopus (311) Google Scholar, 24Llambi F. Causeret F. Bloch-Gallego E. Mehlen P. EMBO J. 2001; 20: 2715-2722Crossref PubMed Scopus (270) Google Scholar, 25Tanikawa C. Matsuda K. Nakanashi H. Fukuda S. Nakamura Y. Arakawa H. Nat. Cell Biol. 2003; 5: 216-223Crossref PubMed Scopus (152) Google Scholar, 26Thiebault K. Mazelin L. Pays L. Llambi F. Joly M.O. Scoazec J.Y. Saurin J.C. Romeo G. Mehlen P. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4173-4178Crossref PubMed Scopus (166) Google Scholar). These receptors were initially proposed as mediators of the chemo-repulsive effects of netrin-1 on specific axons (22Leonardo E.D. Hinck L. Masu M. Keino-Masu K. Ackerman S.L. Tessier-Lavigne M. Nature. 1997; 386: 833-836Crossref PubMed Scopus (420) Google Scholar). Although UNC5H receptors are highly expressed in specific neurons during the development of the nervous system in adults, their expression can also be detected in thyroid, kidney, ovary, uterus, stomach, colon, lung, spleen, bladder, and breast tissues (23Ackerman S.L. Kozak L.P. Przyborski S.A. Rund L.A. Boyer B.B. Knowles B.B. Nature. 1997; 386: 838-842Crossref PubMed Scopus (311) Google Scholar). These observations suggest a role for these receptors away from the neuronal guidance system. Recently, it has been shown that these receptors, when unbound to their ligand, induce apoptosis (24Llambi F. Causeret F. Bloch-Gallego E. Mehlen P. EMBO J. 2001; 20: 2715-2722Crossref PubMed Scopus (270) Google Scholar). One of the UNC5H genes, UNC5H2/B, was recently shown to be a direct transcriptional target of the tumor suppressor p53 and to mediate the proapoptotic activity of p53 (25Tanikawa C. Matsuda K. Nakanashi H. Fukuda S. Nakamura Y. Arakawa H. Nat. Cell Biol. 2003; 5: 216-223Crossref PubMed Scopus (152) Google Scholar). In addition, human UNC5H1, UNC5H2, and UNC5H3 are down-regulated in multiple cancers, and overexpression of these receptors inhibits anchorage-independent growth and invasion of tumor cells (26Thiebault K. Mazelin L. Pays L. Llambi F. Joly M.O. Scoazec J.Y. Saurin J.C. Romeo G. Mehlen P. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4173-4178Crossref PubMed Scopus (166) Google Scholar). Because ZUD is undetectable in the brain, it may have no role in UNC5H-mediated chemo-repulsive effects. However, it is possible that ZUD may be involved in other UNC5H-mediated effects. In transient transfection and co-immunoprecipitation experiments, we found that ZUD could interact with UNC5H2 in 293 cells (data not shown), pointing to the possibility that they are functionally connected. It has been suggested that UNC5H induces apoptosis when it is not bound with its ligand (24Llambi F. Causeret F. Bloch-Gallego E. Mehlen P. EMBO J. 2001; 20: 2715-2722Crossref PubMed Scopus (270) Google Scholar). Our future studies will investigate whether ZUD is involved in this process. Overexpression of ZUD inhibited TNF- and IL1-triggered NF-κB activation, but not IFN-γ-triggered IRF-1 activation, suggesting that ZUD is a specific inhibitor of the NF-κB activation pathways (Fig. 2). In addition, overexpression of ZUD also inhibited TNF-R1-, TRAF2-, TRAF6-, IKKβ-, and p65-induced NF-κB activation (Fig. 2). In gel shift assays, overexpression of ZUD inhibited TNF-induced NF-κB binding to its target sequence (Fig. 3B). Because ZUD is primarily a cytoplasmic protein (Fig. 3A), our original hypothesis was that ZUD might act by retaining NF-κB, especially the p65 subunit, in the cytoplasm. However, immunofluorescent staining experiments indicated that overexpression of ZUD did not block TNF-induced translocation of p65 and p50 to the nucleus (data not shown). Currently, the mechanisms responsible for the inhibitory effects of ZUD are unknown. One of the possibilities is that ZUD affects modification of p65 in the cytoplasm, such as phosphorylation, and this leads to inhibition of NF-κB binding to its target sequence and the subsequent inhibition of NF-κB-mediated transcription. In this context, it has been shown that p65 phosphorylation is important for the full transcription competence of NF-κB (37Naumann M. Scheidereit C. EMBO J. 1994; 13: 4597-4607Crossref PubMed Scopus (325) Google Scholar, 38Neumann M. Grieshammer T. Chuvpilo S. Kneitz B. Lohoff M. Schimpl A. Franza Jr., B.R. Serfling E. EMBO J. 1995; 14: 1991-2004Crossref PubMed Scopus (181) Google Scholar, 39Zhong H Voll R.E. Ghosh S. Mol. Cell. 1998; 1: 661-671Abstract Full Text Full Text PDF PubMed Scopus (1017) Google Scholar, 40Zhong H. SuYang H. Erdjument-Bromage H. Tempst P. Ghosh S. Cell. 1997; 89: 413-424Abstract Full Text Full Text PDF PubMed Scopus (724) Google Scholar, 41Perkins N.D. Felsien L.K. Betts J.C. Leung K. Beach D.H. Nabel G.J. Science. 1997; 275: 523-527Crossref PubMed Scopus (665) Google Scholar). Consistent with its role in inhibiting NF-κB-dependent transcription, ZUD also sensitizes cells to TNF- and TRAIL-induced apoptosis, probably through the inhibition of expression of NF-κB activated anti-apoptotic genes. Taken together, our findings provide evidence that ZUD is a novel NF-κB inhibitor with functional similarity to IκB proteins. Previously, it has been shown that p65 interacts directly with multiple proteins other than the IκB family, including p202 (42Min W. Ghosh S. Lengyel P. Mol. Cell. Biol. 1996; 16: 359-368Crossref PubMed Scopus (142) Google Scholar), CREB-binding protein/p300 (41Perkins N.D. Felsien L.K. Betts J.C. Leung K. Beach D.H. Nabel G.J. Science. 1997; 275: 523-527Crossref PubMed Scopus (665) Google Scholar), Stat 6 (44Shen C.H. Stavnezer J. Mol. Cell. Biol. 1998; 18: 3395-3404Crossref PubMed Google Scholar), TAFII105 (45Yamit-Hezi A. Dikstein R. EMBO J. 1998; 17: 5161-5169Crossref PubMed Scopus (68) Google Scholar), RAI (41Perkins N.D. Felsien L.K. Betts J.C. Leung K. Beach D.H. Nabel G.J. Science. 1997; 275: 523-527Crossref PubMed Scopus (665) Google Scholar), SINK (28Wu M. Xu L. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar), AO7 (43Yang J.P. Hori M. Sanda T. Okamoto T. J. Biol. Chem. 1999; 274: 15662-15670Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar), and BRCA1 (33Asamitsu K. Tetsuka T. Kanazawa S. Okamoto T. J. Biol. Chem. 2003; 278: 26879-26887Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar), which either suppress or activate NF-κB. It is possible that these NF-κB-interacting proteins, including ZUD, are involved in a coordinated regulation of its activity in either a tissue-specific or nonspecific manner. We thank Dr. James Hagman for help with the gel shift assays.

The C-terminal Kinase Domain of the P34cdc2-Related PITSLRE Protein Kinase (p110c) Associates with P21-Activated Kinase 1 and Inhibits Its Activity During Anoikis

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Cyclin Dependent Kinase 5 and Its Interacting Proteins in Cell Death Induced in Vivo by Cyclophosphamide in Developing Mouse Embryos

JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1.

Chromosomal Assignments of the Porcine COPS2, COPS4, COPS5, COPS6, USP6 and USP10 Genes Involved in the Ubiquitin-Proteasome System.

Janus Kinase 2-Dependent Activation of P38 Mitogen-activated Protein Kinase by Growth Hormone

AKT‐dependent Phosphorylation of Niban Regulates Nucleophosmin‐ and MDM2‐mediated P53 Stability and Cell Apoptosis

ZNF216 is an A20-like and IκB Kinase Γ-Interacting Inhibitor of NFκB Activation

Induction of Mitogen-activated Protein Kinase Phosphatase-1 by Arachidonic Acid in Vascular Smooth Muscle Cells

A Left‐Handed Solution to Peptide Inhibition of the P53–mdm2 Interaction

DNA Damage-Induced Apoptosis Requires the DNA-dependent Protein Kinase, and is Mediated by the Latent Population of P53

Identification of a ZU5 and Death Domain-containing Inhibitor of NF-κB

Mitogen-Activated Protein Kinase Phosphatase 2: A Novel Transcription Target of P53 in Apoptosis

Beclin Orthologs: Integrative Hubs of Cell Signaling, Membrane Trafficking, and Physiology

Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2

MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation

Global Investigation of p53-induced Apoptosis Through Quantitative Proteomic Profiling Using Comparative Amino Acid-coded Tagging

Induction of apoptosis by p110C requires mitochondrial translocation of the proapoptotic BCL-2 family member BAD.

Apak competes with p 53 for direct binding to intron 1 of p 53 AIP 1 to regulate apoptosis

Acetylation of P53 Inhibits Its Ubiquitination by Mdm2

The Catalytic Subunit of DNA-dependent Protein Kinase Selectively Regulates P53-Dependent Apoptosis but Not Cell-Cycle Arrest.